sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_7 ;
    pav:version "1.4" .
  sub:_6 prov:value "Such an action is not only surprising in itself, but also in relation to the augmented expression in visceral adipose tissue given the particular association between this fat depot and the metabolic syndrome. Zinc-a2-glycoprotein, the third novel adipokine, is a 43 000 mol. wt glycoprotein which is synthesized by certain malignant tumours and which has been used as a marker for cancer. The protein stimulates lipid loss in cachexia, and this occurs through the activation of lipolysis (Hirai et al. 1998, Todorov et al. 1998, Sanchez et al. 1999) via b3-adrenoceptors (Russell et al. 2002)." ;
    prov:wasQuotedFrom pubmed:16026420 .
  sub:_7 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:16026420 ;
    prov:wasDerivedFrom beldoc: , sub:_6 .
}